Zhou X Y, Tomatsu S, Fleming R E, Parkkila S, Waheed A, Jiang J, Fei Y, Brunt E M, Ruddy D A, Prass C E, Schatzman R C, O'Neill R, Britton R S, Bacon B R, Sly W S
Edward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, 1402 South Grand Boulevard, St. Louis, MO 63104, USA.
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2492-7. doi: 10.1073/pnas.95.5.2492.
Hereditary hemochromatosis (HH) is a common autosomal recessive disease characterized by increased iron absorption and progressive iron storage that results in damage to major organs in the body. Recently, a candidate gene for HH called HFE encoding a major histocompatibility complex class I-like protein was identified by positional cloning. Nearly 90% of Caucasian HH patients have been found to be homozygous for the same mutation (C282Y) in the HFE gene. To test the hypothesis that the HFE gene is involved in regulation of iron homeostasis, we studied the effects of a targeted disruption of the murine homologue of the HFE gene. The HFE-deficient mice showed profound differences in parameters of iron homeostasis. Even on a standard diet, by 10 weeks of age, fasting transferrin saturation was significantly elevated compared with normal littermates (96 +/- 5% vs. 77 +/- 3%, P < 0.007), and hepatic iron concentration was 8-fold higher than that of wild-type littermates (2,071 +/- 450 vs. 255 +/- 23 microg/g dry wt, P < 0.002). Stainable hepatic iron in the HFE mutant mice was predominantly in hepatocytes in a periportal distribution. Iron concentrations in spleen, heart, and kidney were not significantly different. Erythroid parameters were normal, indicating that the anemia did not contribute to the increased iron storage. This study shows that the HFE protein is involved in the regulation of iron homeostasis and that mutations in this gene are responsible for HH. The knockout mouse model of HH will facilitate investigation into the pathogenesis of increased iron accumulation in HH and provide opportunities to evaluate therapeutic strategies for prevention or correction of iron overload.
遗传性血色素沉着症(HH)是一种常见的常染色体隐性疾病,其特征是铁吸收增加和铁进行性储存,导致体内主要器官受损。最近,通过定位克隆鉴定出一个名为HFE的HH候选基因,该基因编码一种主要组织相容性复合体I类样蛋白。已发现近90%的白种人HH患者在HFE基因中具有相同的突变(C282Y)纯合子。为了验证HFE基因参与铁稳态调节这一假说,我们研究了HFE基因小鼠同源物靶向破坏的影响。HFE基因缺陷小鼠在铁稳态参数方面表现出显著差异。即使在标准饮食条件下,到10周龄时,与正常同窝小鼠相比,空腹转铁蛋白饱和度显著升高(96±5%对77±3%,P<0.007),肝脏铁浓度比野生型同窝小鼠高8倍(2071±450对255±23μg/g干重,P<0.002)。HFE突变小鼠肝脏中可染色铁主要分布在门静脉周围的肝细胞中。脾脏、心脏和肾脏中的铁浓度没有显著差异。红细胞参数正常,表明贫血与铁储存增加无关。这项研究表明,HFE蛋白参与铁稳态调节,该基因的突变是HH的病因。HH基因敲除小鼠模型将有助于研究HH中铁蓄积增加的发病机制,并为评估预防或纠正铁过载的治疗策略提供机会。